Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Publications

Search Items: THROMBOPROPHYLAXIS, . hits: 20

2023

Meinel, K; Korak, F; Dusleag, M; Strini, T; Baumgartner, D; Burmas, A; Sallmon, H; Zieger, B; Schlagenhauf, A; Koestenberger, M Mild Acquired von Willebrand Syndrome and Cholestasis in Pediatric and Adult Patients with Fontan Circulation.
J Clin Med. 2023; 12(3): Doi: 10.3390/jcm12031240 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

2022

Gidl, A; Fureder, A; Benesch, M; Dworzak, M; Engstler, G; Jones, N; Kropshofer, G; Potschger, U; Poyer, F; Tamesberger, M; Witt, V; Mann, G; Attarbaschi, A Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group
PEDIATR HEMAT ONCOL. 2022; Doi: 10.1080/08880018.2022.2089791
Web of Science PubMed FullText FullText_MUG

 

Khorana, AA; Mackman, N; Falanga, A; Pabinger, I; Noble, S; Ageno, W; Moik, F; Lee, AYY Cancer-associated venous thromboembolism.
Nat Rev Dis Primers. 2022; 8(1): 11 Doi: 10.1038/s41572-022-00336-y
Web of Science PubMed FullText FullText_MUG

 

2020

Moik, F; Ay, C; Pabinger, I Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future.
Thromb Res. 2020; 191 Suppl 1:S3-S11 Doi: 10.1016/S0049-3848(20)30389-3
Web of Science PubMed FullText FullText_MUG

 

Nopp, S; Moik, F; Jilma, B; Pabinger, I; Ay, C Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.
Res Pract Thromb Haemost. 2020; Doi: 10.1002/rth2.12439 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Mulder, FI; Candeloro, M; Kamphuisen, PW; Di Nisio, M; Bossuyt, PM; Guman, N; Smit, K; Büller, HR; van Es, N; CAT-prediction collaborators The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis.
Haematologica. 2019; 104(6): 1277-1287. Doi: 10.3324/haematol.2018.209114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Pabinger, I; van Es, N; Heinze, G; Posch, F; Riedl, J; Reitter, EM; Di Nisio, M; Cesarman-Maus, G; Kraaijpoel, N; Zielinski, CC; Büller, HR; Ay, C A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Lancet Haematol. 2018; 5(7): e289-e298-e289-e298. Doi: 10.1016/S2352-3026(18)30063-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Bezan, A; Posch, F; Ploner, F; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Gary, T; Samonigg, H; Beyer, J; Winder, T; Hermanns, T; Fankhauser, CD; Gerger, A; Stotz, M Risk stratification for venous thromboembolism in patients with testicular germ cell tumors.
PLoS One. 2017; 12(4):e0176283-e0176283 Doi: 10.1371/journal.pone.0176283 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Posch, F; Gebhart, J; Rand, JH; Koder, S; Quehenberger, P; Pengo, V; Ay, C; Pabinger, I Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.
BMC Med. 2017; 15(1):54-54 Doi: 10.1186/s12916-017-0807-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415 Doi: 10.1186/s12885-017-3392-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Pabinger, I; Posch, F Flamethrowers: blood cells and cancer thrombosis risk.
Hematology Am Soc Hematol Educ Program. 2014; 2014(1): 410-417. Doi: 10.1182/asheducation-2014.1.410 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Watzke, H; Metzler, H; Weltermann, A; Marschang, P; Brodmann, M; Lang, W; Pabinger-Fasching, I; Mahla, E; Kozek-Langenecker, S; Guschmann, M; Huber, K Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts].
Wien Klin Wochenschr. 2013; 125(13-14):412-420 Doi: 10.1007/s00508-013-0390-7
Web of Science PubMed FullText FullText_MUG

 

2012

Schaden, E; Metnitz, PG; Pfanner, G; Heil, S; Pernerstorfer, T; Perger, P; Schoechl, H; Fries, D; Guetl, M; Kozek-Langenecker, S Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care.
Intensive Care Med. 2012; 38(6):984-990 Doi: 10.1007/s00134-012-2533-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Eriksson, BI; Borris, LC; Friedman, RJ; Haas, S; Huisman, MV; Kakkar, AK; Bandel, TJ; Beckmann, H; Muehlhofer, E; Misselwitz, F; Geerts, W; RECORD1 Study Group Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
N Engl J Med. 2008; 358(26): 2765-2775. Doi: 10.1056/NEJMoa0800374 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lassen, MR; Ageno, W; Borris, LC; Lieberman, JR; Rosencher, N; Bandel, TJ; Misselwitz, F; Turpie, AG; RECORD3 Investigators Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
N Engl J Med. 2008; 358(26):2776-2786 Doi: 10.1056/NEJMoa076016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

van Gogh Investigators (with Pilger, E); Buller, HR; Cohen, AT; Davidson, B; Decousus, H; Gallus, AS; Gent, M; Pillion, G; Piovella, F; Prins, MH; Raskob, GE Extended prophylaxis of venous thromboembolism with idraparinux.
N Engl J Med. 2007; 357(11): 1105-1112. Doi: 10.1056/NEJMoa067703 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Thaler, HW; Roller, RE; Greiner, N; Sim, E; Korninger, C Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery.
J Trauma. 2001; 51(3):518-521 Doi: 10.1097/00005373-200109000-00015
Web of Science PubMed FullText FullText_MUG

 

1998

Schippinger, G; Wirnsberger, GH; Obernosterer, A; Babinski, K Thromboembolic complications after arthroscopic knee surgery. Incidence and risk factors in 101 patients.
Acta Orthop Scand. 1998; 69(2):144-146 Doi: 10.3109/17453679809117615 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1993

Reilmann, H; Weinberg, AM; Förster, EE; Happe, B Prevention of thrombosis in ambulatory patients
Orthopade. 1993; 22(2): 117-120.
Web of Science PubMed

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint